• Profile
Close

Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): A factorial, multicentre, cluster-randomised trial

The Lancet Mar 01, 2020

Skjerven HO, Rehbinder EM, Vettukattil R, et al. - A factorial, multicentre, cluster-randomized trial was designed to determine whether either regular skin emollients utilized from 2 weeks of age or early complementary feeding introduced between 12 and 16 weeks of age, reduced development of atopic dermatitis by age 12 months in the general infant population. This trial was performed at Oslo University Hospital and Østfold Hospital Trust, Oslo, Norway; and Karolinska University Hospital, Stockholm, Sweden. This study recruited a total of 2,697 women between Dec 9, 2014, and Oct 31, 2016, from whom 2,397 newborn infants were included from April 14, 2015, to April 11, 2017. The study indicated that neither early skin emollients nor early complementary feeding decreased the growth of atopic dermatitis by age 12 months. This research does not advocate the use of these interventions to prevent atopic dermatitis by 12 months of age in infants.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay